Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - January 2013

Pharmaceutical Microbiology

30 Jan 2013 - 31 Jan 2013 - London, UK

Bookmark and Share

Book by 28th September and receive a £300 discount

Visit to claim your discount now!

Don’t miss SMi’s 2nd annual Pharmaceutical Microbiology conference that aims to provide an expert and highly accredited speaker line up including 13 pharma speakers who will focus on the latest developments and procedures used in the identification and prevention of contaminating agents, updates on new rules and regulations and the challenges facing the Pharmaceutical Microbiology industry. 

Reasons you should not miss this incredible event includes:

Discuss developments in tools, techniques and procedures used in identification and control of contaminants

Evaluate the handling of traditional drug and biologics & sterile product manufacturing 

Hear about design, construction and validation of sterile facilities and equipment

Engage with those currently working on producing the rapid microbial methods

Key Speakers include:

Oliver Chancel, Microbiologist, Sanofi-Aventis

Kim Bowers, Senior Scientist, Pfizer

Praful Bhusari, Associate Scientist, MedImmune

John Duguid, Principle Analytical Scientist, Genzyme

Scott Smith, Microbiology Team Leader, Sanofi-Aventis

Anne Warford, Associate Director, MedImmune

Amy McDaniel, Director, QC Microbiology, Pfizer

Stephen Rawling, Microbiology Team Leader, GlaxoSmithKline

Brendan Gilmore, Research Scientist, Queens University Belfast

Andrew Bartko, Senior Scientist, Battelle Research Institute

Hilary Chan, Quality Scientist IV, Pfizer  

Mark Thompson, Consultant, EPIC Consultancy & Training

Daniel Kockelkorn, Head of PKau Laboratory, Roche 

Emiliano Toso, Principle Scientist, Merck 

Gunther Meike, System Development Specialist, Charles River Laboratories

For more information contact Farhaana Rahman on +44 0 207 827 6186 or email 

Further information
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos